NEW YORK (GenomeWeb) – Response Genetics today after the close of the market reported a 15 percent decrease year over year in its fourth quarter revenues.

For the three months ended Dec. 31, 2014, Response Genetics' total revenues decreased to $4.1 million from $4.8 million in the prior-year period.

Revenue from ResponseDX cancer tests was $3.7 million for the quarter ended Dec. 31, 2014, compared to $3.2 million for the prior-year period, an increase of 16 percent, but revenue from pharmaceutical clients dropped 67 percent to $400,000 in Q4 2014 from $1.6 million in 2013.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Jay Shendure and his colleagues have developed a new method to more comprehensively identify human cell types, the NY Times reports.

Researchers in the UK and Japan have shown that infertility in mice with three sex chromosomes can be overcome, according to the Guardian.

China is embracing preimplantation genetic diagnosis, Nature News reports. 

In PLOS this week: host genetic factors associated with cervical neoplasia progression, population patterns for an ancient flowering rainforest plant, and more.